Structural Equation Modeling for Analyzing Erythrocyte Fatty Acids in Framingham
Table 1
Framingham subjects’ fatty acids; mean (SD).
Fatty acid
Overall
Male
Female
value*
Myristic, C14:0
0.31 (0.08)
0.29 (0.07)
0.32 (0.09)
<0.0001
Palmitic, C16:0
21.29 (1.24)
21.24 (1.21)
21.34 (1.26)
0.031
Stearic, C18:0
18.11 (0.95)
18.20 (0.89)
18.04 (1.00)
<0.0001
Lignoceric, C24:0
0.43 (0.16)
0.44 (0.16)
0.42 (0.16)
0.012
Palmitoleic, C16:1
0.35 (0.19)
0.31 (0.18)
0.39 (0.19)
<0.0001
Oleic, C18:1
13.88 (1.06)
13.90 (1.06)
13.85 (1.06)
0.23
Eicosenoic, C20:1
0.27 (0.11)
0.28 (0.12)
0.27 (0.10)
<0.0001
Nervonic, C24:1
0.45 (0.15)
0.46 (0.15)
0.43 (0.15)
<0.0001
trans Palmitoleic, C16:1 trans
0.17 (0.05)
0.16 (0.05)
0.17 (0.05)
0.0052
trans Oleic, C18:1 trans
1.62 (0.55)
1.62 (0.57)
1.61 (0.54)
0.56
trans Linoleic, C18:2 trans
0.25 (0.08)
0.24 (0.08)
0.25 (0.08)
0.0021
alpha-Linolenic, C18:3n3
0.19 (0.10)†
0.17 (0.09)
0.20 (0.11)
<0.0001
Eicosapentaenoic (EPA), C20:5n3
0.74 (0.46)†
0.71 (0.42)
0.76 (0.49)
0.0011
Docosapentaenoic, C22:5n3
2.74 (0.46)
2.80 (0.46)
2.70 (0.45)
<0.0001
Docosahexaenoic (DHA), C22:6n3
4.88 (1.38)
4.82 (1.39)
4.92 (1.37)
0.043
Linoleic, C18:2n6
11.19 (1.74)
11.03 (1.63)
11.33 (1.81)
<0.0001
gamma-Linolenic, C18:3n6
0.08 (0.09)
0.08 (0.12)
0.09 (0.07)
0.089
Eicosadienoic, C20:2n6
0.28 (0.05)
0.28 (0.05)
0.28 (0.05)
0.23
Eicosatrienoic, C20:3n6
1.59 (0.36)
1.59 (0.36)
1.59 (0.35)
0.66
Arachidonic, C20:4n6
16.78 (1.62)
16.79 (1.57)
16.77 (1.66)
0.66
Docosatetraenoic, C22:4n6
3.76 (0.83)
3.92 (0.83)
3.63 (0.81)
<0.0001
Docosapentaenoic, C22:5n6
0.66 (0.19)
0.67 (0.19)
0.64 (0.19)
<0.0001
Two-sample -test, the critical level alpha was set to 0.05/22 = 0.0023 for statistical significance using Bonferroni correction (shown in bold). Use the following mean (SD) of the log-transformed values when standardizing data as explained in the discussion section for C18:3n3 −6.38 (0.41) and C20:5n3 −5.04 (0.48).
